Barclays initiated coverage on PerkinElmer with a new price target
$PKI
Biotechnology: Laboratory Analytical Instruments
Industrials
Barclays initiated coverage of PerkinElmer with a rating of Underweight and set a new price target of $125.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/19/2022 | $170.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 12/12/2022 | $135.00 → $170.00 | Neutral → Buy | Citigroup |
| 12/6/2022 | $192.00 → $164.00 | Market Perform → Outperform | Cowen |
| 11/28/2022 | $130.00 → $145.00 | Underweight → Equal Weight | Barclays |
| 8/25/2022 | $175.00 | Neutral | Credit Suisse |
| 8/18/2022 | $190.00 → $170.00 | Buy → Hold | Stifel |
| 8/2/2022 | $178.00 | Buy → Neutral | BofA Securities |
| 7/20/2022 | $160.00 | Buy | UBS |